Significats de cholinesterase inhibitor en anglès

This study shows that the two long-term cholinesterase inhibitor treatments exert different effects on biological markers for AD.

Background: There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD).

All patients who entered the trial had previously failed to respond to a structurally related cholinesterase inhibitor without adrenergic properties (HP 029).

Treatment with oral cholinesterase inhibitors produced a dramatic improvement in muscle strength.

Complex interactions between the effects of local and systemic cholinesterase inhibitors were observed.

Avoid contact with carbamate or organo-phosphate insecticides and pesticides while using cholinesterase inhibitors.

These findings may have an important influence on the way cholinesterase inhibitors are prescribed.

This review presents the main classes of cholinesterase inhibitors developed recently for the treatment of AD.

These results suggest that there are significant differences in the mechanisms of action of various cholinesterase inhibitors.

Among various attempts to enhance cholinergic neurotransmission in AD clinical trials with cholinesterase inhibitors have been most promising.

Cholinesterase inhibitors used to treat Alzheimer's

Cholinesterase inhibitors are effective treatments for dementia in PD, but improvement is modest and motor side effects may occur.

Increase in cerebral glucose metabolism has also been measured following fairly long periods of treatment with cholinesterase inhibitors (months).

If you are taking cholinesterase inhibitors to control it, using topical cholinesterase inhibitors puts you at greater risk for adverse effects.

The first group of patients received only the drug while the second group received cholinesterase inhibitors in addition to MEM 1003.

Cholinesterase inhibitors are a group of drugs prescribed to treat symptoms resulting from the early and middle stages of Alzheimer disease.